Special Investigation in Patients With Intestinal Behcet's Disease (All Case Investigation)
Phase of Trial: Phase IV
Latest Information Update: 30 May 2017
At a glance
- Drugs Adalimumab (Primary)
- Indications Behcet's syndrome
- Focus Adverse reactions
- Sponsors AbbVie
- 10 Jun 2017 Biomarkers information updated
- 30 May 2017 Status changed from active, no longer recruiting to completed.
- 03 Aug 2016 Planned primary completion date changed from 1 Jan 2017 to 1 Apr 2017.